APA (7th ed.) Citation
Dos Santos, G., Devadiga, R., Kim, C. S., & Bang, J. (2024). An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug Safety, 47(4), 365-376.
Chicago Style (17th ed.) Citation
Dos Santos, Gaël, Raghavendra Devadiga, Chun Soo Kim, and Joon Bang. "An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older." Drug Safety 47, no. 4 (2024): 365-376.
MLA (9th ed.) Citation
Dos Santos, Gaël, et al. "An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older." Drug Safety, vol. 47, no. 4, 2024, pp. 365-376.
Warning: These citations may not always be 100% accurate.